Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Paediatrics
  4. Back
  5. Infectious Disease (Paediatric)
  6. Isolates reported as 'I' (susceptible increased exposure) - dosing schedules for neonates and children (944)
Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. 

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Isolates reported as 'I' (susceptible increased exposure) - dosing schedules for neonates and children (944)

Antibiotic dosing guidelines: Treatment of isolates reported as ‘I’ – dosing schedules for neonates and children.

Purpose and Scope:
The purpose of this guideline is to provide antibiotic dosing guidance for use in neonates and children where isolates are reported as ‘I’ on microbiology reports, or where advised by the Microbiology or Infectious Diseases Teams. A susceptibility category of ‘I’ indicates that a specific dosing schedule is required in order for the antibiotic to effectively treat the infecting organism.

The scope of this guidance encompasses the management of neonates and children treated in NHS Greater Glasgow and Clyde. The doses advised in this guidance are relevant only in certain ‘bug-drug’ combinations and should be used ONLY where a susceptibility category of ‘I’ has been assigned, or where specifically recommended by a specialist in infection management.

The doses in the guidance may not be applicable to the management of meningitis. Clinical breakpoints for meningitis may differ from breakpoints for non-meningitic conditions – it must not be assumed that these breakpoints and susceptibility reports are interchangeable. Contact Microbiology for further advice.

The doses advised in this guidance are appropriate for patients with normal renal and hepatic function. Where there is known or suspected renal or hepatic impairment a risk vs benefit decision should be made, taking in to account the increased exposure required to treat the organism effectively.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 16/08/2022

Next review date: 31/08/2023

Author(s): Susan Kafka.

Version: 2

Approved By: Antimicrobial Utilisation Committee

Document Id: 944